A Phase 2 Randomised Controlled Dose-Ranging Trial of Recombinant Pertussis Booster Vaccines Containing Genetically Inactivated Pertussis Toxin in Pregnant Women

MLA

Thanyawee Puthanakit, et al. “A Phase 2 Randomised Controlled Dose-Ranging Trial of Recombinant Pertussis Booster Vaccines Containing Genetically Inactivated Pertussis Toxin in Pregnant Women.” SSRN Electronic Journal, Jan. 2022. EBSCOhost, https://doi.org/10.2139/ssrn.4196976.

APA

Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, Niranjan Bhat, Yuxiao Tang, Suvaporn Anugulruengkitt, Chenchit Chayachinda, Sanitra Anuwutnavin, Keswadee Lapphra, Supattra Rungmaitree, Monta Tawan, Indah Andi-Lolo, Renee Holt, Librada Fortuna, Chawanee Kerdsomboon, Vilasinee Yuwaree, Souad Mansouri, Pham Hong Thai, & Bruce L. Innis. (2022). A Phase 2 Randomised Controlled Dose-Ranging Trial of Recombinant Pertussis Booster Vaccines Containing Genetically Inactivated Pertussis Toxin in Pregnant Women. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4196976

Chicago

Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, Niranjan Bhat, Yuxiao Tang, Suvaporn Anugulruengkitt, Chenchit Chayachinda, et al. 2022. “A Phase 2 Randomised Controlled Dose-Ranging Trial of Recombinant Pertussis Booster Vaccines Containing Genetically Inactivated Pertussis Toxin in Pregnant Women.” SSRN Electronic Journal, January. doi:10.2139/ssrn.4196976.